STRATA Skin Sciences (SSKN) Common Equity (2010 - 2025)

STRATA Skin Sciences' Common Equity history runs 16 years deep, the most recent figure standing at $2.9 million for Q4 2025.

• In Q4 2025, Common Equity fell 41.51% year-over-year to $2.9 million; the TTM figure through Dec 2025 stood at $2.9 million (down 41.51% YoY), while the FY2025 annual figure was $2.9 million, down 41.51% from the prior year.
• Common Equity came in at $2.9 million for Q4 2025 at STRATA Skin Sciences, up from $1.3 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $26.2 million in Q3 2021 to a low of $532000.0 in Q2 2025.
• A 5-year average of $14.9 million and a median of $16.6 million in 2023 frame the typical range for Common Equity.
• Across the five-year window, Common Equity climbed 0.99% in 2021 and slumped 94.4% in 2025, its largest moves.
• STRATA Skin Sciences' Common Equity stood at $25.4 million in 2021, then decreased by 14.1% to $21.8 million in 2022, then sank by 41.88% to $12.7 million in 2023, then sank by 60.81% to $5.0 million in 2024, then slumped by 41.51% to $2.9 million in 2025.
• According to Business Quant data, Common Equity over the past three periods registered $2.9 million, $1.3 million, and $532000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison